![PDF) Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey PDF) Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey](https://i1.rgstatic.net/publication/263014264_Prognostic_factors_in_elderly_patients_with_malignant_pleural_mesothelioma_Results_of_a_multicenter_survey/links/54ee62b50cf25238f93a4805/largepreview.png)
PDF) Prognostic factors in elderly patients with malignant pleural mesothelioma: Results of a multicenter survey
![Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment | Cancer Cell International | Full Text Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-019-1037-1/MediaObjects/12935_2019_1037_Fig2_HTML.png)
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment | Cancer Cell International | Full Text
![PDF) Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment PDF) Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment](https://i1.rgstatic.net/publication/337637656_Cisplatin-resistant_A549_non-small_cell_lung_cancer_cells_can_be_identified_by_increased_mitochondrial_mass_and_are_sensitive_to_pemetrexed_treatment/links/5de1cdfa92851c8364549003/largepreview.png)
PDF) Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
![A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells | Cell Death & Disease A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcddis.2013.315/MediaObjects/41419_2013_Article_BFcddis2013315_Fig1_HTML.jpg)
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells | Cell Death & Disease
![IJMS | Free Full-Text | Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer IJMS | Free Full-Text | Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer](https://www.mdpi.com/ijms/ijms-22-06228/article_deploy/html/images/ijms-22-06228-g001.png)
IJMS | Free Full-Text | Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer
![Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer | Cell Death & Disease Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcddis.2013.554/MediaObjects/41419_2014_Article_BFcddis2013554_Fig2_HTML.jpg)
Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer | Cell Death & Disease
Piccolino Nottingham - Reviews - Nottingham, United Kingdom - Menu, prices, restaurant reviews | Facebook
![Targeted OMA1 therapies for cancer - Alavi - 2019 - International Journal of Cancer - Wiley Online Library Targeted OMA1 therapies for cancer - Alavi - 2019 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/33b55e8e-c242-4b61-bf7e-fe46bb286380/ijc.v145.9.cover.jpg?trick=1682665470625)
Targeted OMA1 therapies for cancer - Alavi - 2019 - International Journal of Cancer - Wiley Online Library
![Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy - Journal of Pharmaceutical Sciences Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/2046479523/2057601790/gr1.jpg)
Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy - Journal of Pharmaceutical Sciences
![Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer | Cell Death & Disease Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fcddis.2013.554/MediaObjects/41419_2014_Article_BFcddis2013554_Fig1_HTML.jpg)